{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:56:53Z","timestamp":1789585013793,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.anai.2024.03.009","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T16:28:41Z","timestamp":1710606521000},"page":"64-72.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma"],"prefix":"10.1016","volume":"133","author":[{"given":"Dan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Baines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Chen-Yu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2024.03.009_bib0001","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention. Accessed March 10, 2022. Available at: https:\/\/ginasthma.org\/"},{"issue":"2","key":"10.1016\/j.anai.2024.03.009_bib0002","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2024.03.009_bib0003","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pccm.2023.04.003","article-title":"Emerging roles and therapeutic implications of HDAC2 and IL-17A in steroid-resistant asthma","volume":"1","author":"Ouyang","year":"2023","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2024.03.009_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.11.015","article-title":"Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health National Heart, Lung, and Blood Institute Severe Asthma Research Program","volume":"127","author":"Fitzpatrick","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2024.03.009_bib0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2006.11.639","article-title":"Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program","volume":"119","author":"Moore","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2024.03.009_bib0006","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pccm.2023.08.001","article-title":"From gene identifications to therapeutic targets for asthma: focus on great potentials of TSLP, ORMDL3, and GSDMB","volume":"1","author":"Zhang","year":"2023","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"21-22","key":"10.1016\/j.anai.2024.03.009_bib0007","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.lfs.2012.08.030","article-title":"The non-neuronal cholinergic system as novel drug target in the airways","volume":"91","author":"Pieper","year":"2012","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.anai.2024.03.009_bib0008","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pharmthera.2007.05.007","article-title":"The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?","volume":"115","author":"Gwilt","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"18-19","key":"10.1016\/j.anai.2024.03.009_bib0009","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0024-3205(03)00063-8","article-title":"Introduction: the non-neuronal cholinergic system in humans","volume":"72","author":"Grando","year":"2003","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.anai.2024.03.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01247-2017","article-title":"The mode of action of anticholinergics in asthma","volume":"52","author":"Gosens","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.anai.2024.03.009_bib0011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tips.2014.11.005","article-title":"Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling","volume":"36","author":"Kistemaker","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0012","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1465-9921-7-73","article-title":"Muscarinic receptor signaling in the pathophysiology of asthma and COPD","volume":"7","author":"Gosens","year":"2006","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.anai.2024.03.009_bib0013","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/pupt.2001.0313","article-title":"The non-neuronal cholinergic system: an emerging drug target in the airways","volume":"14","author":"Wessler","year":"2001","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.anai.2024.03.009_bib0014","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.alit.2018.02.008","article-title":"Possible involvement of acetylcholine-mediated inflammation in airway diseases","volume":"67","author":"Koarai","year":"2018","journal-title":"Allergol Int"},{"issue":"6","key":"10.1016\/j.anai.2024.03.009_bib0015","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2020.06.014","article-title":"The latest on the role of LAMAs in asthma","volume":"146","author":"Cazzola","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2024.03.009_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rmed.2019.06.008","article-title":"Tiotropium in asthma: from bench to bedside","volume":"154","author":"Mansfield","year":"2019","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.anai.2024.03.009_bib0017","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/17476348.2017.1289844","article-title":"Role of muscarinic antagonists in asthma therapy","volume":"11","author":"Cazzola","year":"2017","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0018","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12931-016-0467-8","article-title":"Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients","volume":"17","author":"Milara","year":"2016","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.anai.2024.03.009_bib0019","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.21037\/jtd.2017.04.74","article-title":"Severe and uncontrolled asthma in China: a cross-sectional survey from the Australasian Severe Asthma Network","volume":"9","author":"Wang","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.anai.2024.03.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106924","article-title":"Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: a prospective cohort study","volume":"200","author":"Liu","year":"2022","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.anai.2024.03.009_bib0021","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2021.04.065","article-title":"Total IgE variability is associated with future asthma exacerbations: a 1-year prospective cohort study","volume":"9","author":"Yuan","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2024.03.009_bib0022","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2024.03.009_bib0023","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0024","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12931-019-1051-9","article-title":"Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations","volume":"20","author":"Liu","year":"2019","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0025","doi-asserted-by":"crossref","first-page":"pbad003","DOI":"10.1093\/pcmedi\/pbad003","article-title":"Workup of difficult-to-treat asthma: implications from treatable traits","volume":"6","author":"Zhang","year":"2023","journal-title":"Precis Clin Med"},{"issue":"4","key":"10.1016\/j.anai.2024.03.009_bib0026","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1183\/13993003.01098-2015","article-title":"Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma","volume":"47","author":"Wang","year":"2016","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2024.03.009_bib0027","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000245899","article-title":"Assessment and reproducibility of non-eosinophilic asthma using induced sputum","volume":"79","author":"Simpson","year":"2010","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.anai.2024.03.009_bib0029","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jaci.2013.12.1091","article-title":"Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes","volume":"133","author":"Baines","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2024.03.009_bib0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4168\/aair.2022.14.4.393","article-title":"Sputum metabolomic profiling reveals metabolic pathways and signatures associated with inflammatory phenotypes in patients with asthma","volume":"14","author":"Liu","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"issue":"5","key":"10.1016\/j.anai.2024.03.009_bib0031","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00408-022-00570-x","article-title":"Endogenous adenosine 5\u2019-monophosphate, but not acetylcholine or histamine, is associated with asthma control, quality of life, and exacerbations","volume":"200","author":"Fang","year":"2022","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2024.03.009_bib0033","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.anai.2024.03.009_bib0034","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.03.00261903","article-title":"The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European network for understanding mechanisms of severe asthma","volume":"22","year":"2003","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphs.2017.05.002","article-title":"Physiological functions of the cholinergic system in immune cells","volume":"134","author":"Fujii","year":"2017","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.anai.2024.03.009_bib0036","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/COPD.S285867","article-title":"The impact of muscarinic receptor antagonists on airway inflammation: a systematic review","volume":"16","author":"Calzetta","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0037","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pupt.2012.07.003","article-title":"Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target","volume":"26","author":"Meurs","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.anai.2024.03.009_bib0038","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2017.01.014","article-title":"A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma","volume":"140","author":"Szefler","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.03.009_bib0039","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01100-2016","article-title":"A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma","volume":"49","author":"Hamelmann","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2024.03.009_bib0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.rmed.2016.06.013","article-title":"Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status","volume":"117","author":"Kerstjens","year":"2016","journal-title":"Respir Med"},{"issue":"13","key":"10.1016\/j.anai.2024.03.009_bib0041","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.anai.2024.03.009_bib0042","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2024.03.009_bib0043","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2500\/aap.2016.37.3991","article-title":"Effects of the addition of tiotropium on airway dimensions in symptomatic asthma","volume":"37","author":"Hoshino","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2024.03.009_bib0044","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2147\/COPD.S137587","article-title":"Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction","volume":"12","author":"Toumpanakis","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"9","key":"10.1016\/j.anai.2024.03.009_bib0045","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.anai.2024.03.009_bib0046","first-page":"1026","article-title":"Kinetic PCR analysis: real-time monitoring of DNA amplification reactions","volume":"11","author":"Higuchi","year":"1993","journal-title":"Biotechnology (NY)"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624001509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624001509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T21:17:04Z","timestamp":1731964624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624001509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1081120624001509"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.03.009","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}